Variants in angiogenesis-related genes and the risk of clear cell renal cell carcinoma

Mutagenesis. 2014 Nov;29(6):419-25. doi: 10.1093/mutage/geu046. Epub 2014 Sep 18.

Abstract

Angiogenesis is fundamentally important to the pathogenesis of clear cell renal cell carcinoma (ccRCC). We investigated the association between variations of genes related to angiogenesis and the risk of ccRCC. In a case-control study of 859 ccRCC patients and 1004 cancer-free subjects, we genotyped 24 potentially functional single nucleotide polymorphisms (SNPs) in seven angiogenesis-related genes (HIF1A, EPAS1, VEGFA, VEGFR1, VEGFR2, VEGFR3 and PDGFRB) using the TaqMan or Snapshot method. Unconditional logistic regression, adjusted for potential confounding factors, was used to assess the risk associations. The functionality of selected SNPs was assessed by real-time quantitative reverse transcription polymerase chain reaction (RT-PCR) and luciferase reporter gene assays. We found two SNPs (VEGFA rs2010963 and VEGFR3 rs448012) that were significantly associated with increased risk of ccRCC, after adjusting for multiple comparisons [rs2010963 CC/GC cf. GG: false discovery rate (FDR) = 0.048, odds ratio (OR) = 1.36, 95% confidence interval (95% CI) = 1.12-1.66; rs448012 CC/GC cf. GG: FDR = 0.048, OR = 1.38, 95% CI =1.13-1.69]. Real-time quantitative PCR revealed that the variant genotypes of rs2010963, but not rs448012, were associated with increased gene expression in normal tissues of ccRCC patients (CC/GC cf. GG: P = 0.036). The luciferase reporter assay showed that the rs2010963 C allele significantly increased luciferase activity over that of the rs2010963 G allele. Our results indicate that VEGFA rs2010963 and VEGFR3 rs448012 are associated with risk of ccRCC. Furthermore, rs2010963 is a functional SNP that may affect ccRCC susceptibility by modulating endogenous VEGFA expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Renal Cell / blood supply*
  • Carcinoma, Renal Cell / genetics*
  • Carcinoma, Renal Cell / pathology
  • Case-Control Studies
  • Gene Expression Regulation, Neoplastic
  • Genes, Reporter
  • Genetic Association Studies
  • Genetic Predisposition to Disease*
  • Humans
  • Kidney Neoplasms / blood supply*
  • Kidney Neoplasms / genetics*
  • Kidney Neoplasms / pathology
  • Luciferases / metabolism
  • Middle Aged
  • Neovascularization, Pathologic / genetics*
  • Plasmids / metabolism
  • Polymorphism, Single Nucleotide / genetics
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Risk Factors
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor Receptor-3 / genetics

Substances

  • RNA, Messenger
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Luciferases
  • FLT4 protein, human
  • Vascular Endothelial Growth Factor Receptor-3